Cite
HARVARD Citation
Giuliani, C. et al. (2021). Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced "cytokines storm". Medical hypotheses. p. . [Online].